BCLS Acquisition Corp.

BCLS Acquisition Corp. (Nasdaq: BLSA) is a blank-check company sponsored by Bain Capital Life Sciences that filed its S-1 registration statement with the SEC on October 2, 2020, and completed its initial public offering later that year. The vehicle was formed to pursue an acquisition in the life sciences sector, with a focus on biopharmaceutical and medical technology businesses where the sponsor's deep industry expertise could add strategic value. BCLS subsequently announced a business combination with Imago BioSciences, a clinical-stage hematology company. Readers looking for complete filing history, sponsor background, and deal-timeline data on BLSA can sign up for full access at SpacDesk.